Department of Radiation Therapy, Jean Bernard Center, 9 Rue Beauverger, 72000, Le Mans, France.
Department of Radiation Therapy, Integrative Center of Oncology (Paul Papin), 15 rue Bocquel, 49055, Angers Cedex 2, France.
Support Care Cancer. 2018 Jun;26(6):1897-1903. doi: 10.1007/s00520-017-4001-4. Epub 2017 Dec 23.
The palliative treatment for cervico-thoracic spinal metastases is based on a three-dimensional conformal radiation therapy (3D-CRT). Digestive toxicities are common and cause a clinical impact frequently underestimated in patients. We performed a retrospective study of digestive side effects occurring after palliative 3D-CRT for cervico-thoracic spinal metastases.
All patients receiving palliative 3D-CRT at Jean Bernard Center from January 2013 to December 2014 for spinal metastases between the 5th cervical vertebra (C5) and the 12th thoracic vertebra (T12) were eligible. Three-dimensional conformal RT was delivered by a linear accelerator (CLINAC, Varian). Premedication to prevent digestive toxicities was not used. Adverse events ("esophagitis" and "nausea and/or vomiting") were evaluated according to the NCI-CTCae (version 4).
From January 2013 to December 2014, 128 patients met the study criteria. The median age was 68.6 years [31.8; 88.6]. Most patients (84.4%) received 30 Gy in 10 fractions. The median overall time of treatment was 13 days [3-33]. Forty patients (31.3%) suffered from grade ≥ 2 of "esophagitis" (35 grade 2 (27.4%) and 5 grade 3 (3.9%)). Eight patients (6.3%) suffered from grade ≥ 2 of "nausea and/or vomiting" (6 grade 2 (4.7%), 1 grade 3 (0.8%), and 1 grade 4 (0.8%)).
The high incidence of moderate to severe digestive toxicities after palliative 3D-CRT for cervico-thoracic spinal metastases led to consider static or dynamic intensity-modulated radiation therapy (IMRT) to reduce the dose to organ at risk (the esophagus and stomach). Dosimetric studies and implementation in the clinic should be the next steps.
颈椎胸段脊柱转移的姑息性治疗基于三维适形放疗(3D-CRT)。消化道毒性很常见,并且经常导致患者低估其临床影响。我们对接受姑息性 3D-CRT 治疗的颈椎胸段脊柱转移患者的消化道副作用进行了回顾性研究。
2013 年 1 月至 2014 年 12 月期间,Jean Bernard 中心接受姑息性 3D-CRT 治疗的第 5 颈椎(C5)至第 12 胸椎(T12)脊柱转移患者符合入选标准。采用直线加速器(CLINAC,Varian)进行 3D-CRT。未使用预防消化道毒性的预处理药物。根据 NCI-CTCae(第 4 版)评估不良事件(“食管炎”和“恶心和/或呕吐”)。
2013 年 1 月至 2014 年 12 月,符合研究标准的患者共 128 例。中位年龄为 68.6 岁[31.8;88.6]。大多数患者(84.4%)接受 30 Gy 分 10 次照射。中位总治疗时间为 13 天[3-33]。40 例(31.3%)患者发生≥2 级“食管炎”(35 例 2 级[27.4%]和 5 例 3 级[3.9%])。8 例(6.3%)患者发生≥2 级“恶心和/或呕吐”(6 例 2 级[4.7%],1 例 3 级[0.8%]和 1 例 4 级[0.8%])。
颈椎胸段脊柱转移姑息性 3D-CRT 后,中重度消化道毒性发生率较高,因此考虑采用静态或动态调强放疗(IMRT)以降低危及器官(食管和胃)的剂量。剂量学研究和临床实施应是下一步工作。